CLINICAL TRIALS PROFILE FOR MOVIPREP
✉ Email this page to a colleague
All Clinical Trials for Moviprep
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00312481 ↗ | MOVIPREP® Versus PICOLAX® Pilot Study | Completed | Norgine | Phase 2 | 2005-07-01 | This will be a randomised, single-centre, single-blind, parallel-group, pilot study in patients undergoing colonoscopy. The primary objective is to evaluate the efficacy of MOVIPREP® versus PICOLAX® for gut cleansing prior to colonoscopy. The secondary objectives are to evaluate the safety, tolerability and acceptability of MOVIPREP versus PICOLAX for gut cleansing prior to colonoscopy. |
| NCT00322062 ↗ | MOVIPREP® Versus NaP Pivotal Phase III Study | Completed | Norgine | Phase 3 | 2002-04-01 | The aim of the study is to compare a new 2 litre bowel cleansing product versus a sodium phosphate solution already on the market. Efficacy of each bowel preparation, safety and acceptability will be assessed. |
| NCT00389233 ↗ | A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution | Completed | Norgine | Phase 3 | 2002-06-01 | The study was carried out as a randomised, single-blind, active-controlled, multi-centric, phase III study with two parallel treatment groups. The primary efficacy criterion was the frequency of effective gut cleansing in each of the two treatment groups (grade A or B "overall quality of gut cleansing" as judged by a blinded expert panel on the basis of videotapes recorded during the endoscopic procedure). |
| NCT00427089 ↗ | Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening | Completed | Norgine | Phase 3 | 2004-09-01 | To compare the efficacy, acceptability and safety of the new 2 liter gut cleansing solution (Moviprep) and NaP preparation in routine colon cleansing prior to tumor screening colonoscopies |
| NCT00605228 ↗ | A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation | Completed | International Clinical Trials Association | Phase 4 | 2007-05-01 | Primary: - To demonstrate the superiority of Moviprep® versus Colopeg® in gut cleansing prior to colonoscopy. Secondary: - To assess the safety of Moviprep® versus Colopeg®. - To assess acceptability of Moviprep® versus Colopeg®. |
| NCT00605228 ↗ | A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation | Completed | Norgine | Phase 4 | 2007-05-01 | Primary: - To demonstrate the superiority of Moviprep® versus Colopeg® in gut cleansing prior to colonoscopy. Secondary: - To assess the safety of Moviprep® versus Colopeg®. - To assess acceptability of Moviprep® versus Colopeg®. |
| NCT00618930 ↗ | Moviprep® Versus Fleet Phospho-Soda® (Golden Standard): A Study That Compared Two Laxatives on Patients Undergoing Colo-Rectal Cleansing Prior to an Abdominal Operation | Completed | University Hospital, Ghent | Phase 4 | 2008-02-01 | The patients are assigned by randomisation on one of the two laxatives. After cleansing they have to fill in an evaluation form to report their findings and difficulties. Also the surgeon will be asked to fill in a score-form to report all details concerning the bowel preparation. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Moviprep
Condition Name
Clinical Trial Locations for Moviprep
Trials by Country
Clinical Trial Progress for Moviprep
Clinical Trial Phase
Clinical Trial Sponsors for Moviprep
Sponsor Name
